Piper Jaffray Reiterates Overweight on Mallinckrodt (MNK) Following Solid 1Q Results

Go back to Piper Jaffray Reiterates Overweight on Mallinckrodt (MNK) Following Solid 1Q Results

Mizuho Securities Upgrades Mallinckrodt plc (MNK) to Buy

February 3, 2016 6:39 AM EST

Mizuho Securities upgraded Mallinckrodt plc (NYSE: MNK) from Neutral to Buy with a price target of $78.00 (from $72.00).

Analyst Irina Koffler commented, "We are upgrading MNK from Neutral to Buy and raising our PT from $72 to $78. We were previously concerned with commercial... More

Pre-Open Stock Movers 02/02: (HNSN) (KORS) (GOOGL) (GOOG) Higher; (ZINC) (IDTI) (HEAR) Lower (more...)

February 2, 2016 9:26 AM EST

Horsehead Holding Corp. (Nasdaq: ZINC) 53.7% LOWER; announced today that it and certain of its subsidiaries have filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.

Hansen Medical, Inc. (NASDAQ: HNSN) 22.8% HIGHER; received U.S. Food... More

Mallinckrodt (MNK) Tops Q1 EPS by 23c

February 2, 2016 6:13 AM EST

Mallinckrodt (NYSE: MNK) reported Q1 EPS of $2.00, $0.23 better than the analyst estimate of $1.77. Revenue for the quarter came in at $915 million versus the consensus estimate of $888.33 million.

Exceptional Specialty Brands segment performance, up 45.4%, was the primary growth contributor driven by solid organic... More

Trading Radar for 2/2: Yahoo! (YHOO). ExxonMobil (XOM), Ferrari (RACE), Chipotle (CMG), UPS (UPS) Report

February 1, 2016 3:29 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

ADT Corp. (NYSE: ADT) - consensus EPS $0.46
AGCO Corp. (Nasdaq: AGCO) - consensus EPS $0.79
Affiliated Managers Group (NYSE: AMG) - consensus EPS $3.60
Ally Financial (NYSE: ALLY) - consensus EPS $0.51
Anixter Int'l (NYSE: AXE) - consensus EPS $1.10
Archer Daniels Midland (NYSE:... More

Mallinckrodt (MNK) Announces Completion of Hemostasis Drug Portfolios Acquisition from Medicines Co. (MDCO)

February 1, 2016 8:51 AM EST

Mallinckrodt plc (NYSE: MNK) announced it closed the acquisition of the global portfolio of three commercial-stage topical hemostasis drugs from The Medicines Company. The portfolio includes RECOTHROM® Thrombin topical (Recombinant), PreveLeak Surgical Sealant, and RAPLIXA (Fibrin Sealant (Human)).

Under Mallinckrodt's acquire to invest operating model, the company will invest in market development of RECOTHROM, PreveLeak and RAPLIXA, all innovative, highly durable hemostasis products that increase surgeons' choices. The... More